Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record, with a small difference in title or year; 65 of the 70 references it cites were found in a registry or an index.

Role of the HSP90-Associated Cochaperone p23 in Enhancing Activity of the Androgen Receptor and Significance for Prostate Cancer

Open access

Abstract

Prostate tumor growth initially depends on androgens, which act via the androgen receptor (AR). Despite androgen ablation therapy, tumors eventually progress to a castrate-resistant stage in which the AR remains active. The mechanisms are poorly understood but it may be that changes in levels or activity of AR coregulators affect trafficking and activation of the receptor. A key stage in AR signaling occurs in the cytoplasm, where unliganded receptor is associated with the heat shock protein (HSP)90 foldosome complex. p23, a key component of this complex, is best characterized as a cochaperone for HSP90 but also has HSP90-independent activity and has been reported as having differential effects on the activity of different steroid receptors. Here we report that p23 increases activity of the AR, and this appears to involve steps both in the cytoplasm (increasing ligand-binding capacity, possibly via direct interaction with AR) and the nucleus (enhancing AR occupancy at target promoters). We show, for the first time, that AR and p23 can interact, perhaps directly, when HSP90 is not present in the same complex. The effects of p23 on AR activity are at least partly HSP90 independent because a mutant form of p23, unable to bind HSP90, nevertheless increases AR activity. In human prostate tumors, nuclear p23 was higher in malignant prostate cells compared with benign/normal cells, supporting the utility of p23 as a therapeutic target in prostate cancer.

Overview

Integrity signals

Registry

Crossref · 10.1210/me.2012-1056

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Cited by

See all 47

Metadata

Authors
Reebye, V., Querol Cano, L., Lavery, D. N., Brooke, G. N., Powell, S. M., Chotai, D., Walker, M. M., Whitaker, H. C., Wait, R., Hurst, H. C., & Bevan, C. L.
Affiliations
  • Queen Mary University of London (GB)
  • Androgen Signalling Laboratory (V.R., L.Q.C., G.N.B., S.M.P., D.N.L., D.C., C.L.B.), Department of Surgery & Cancer, Imperial College London, London W12 0NN, United Kingdom;
Venue
Molecular Endocrinology
Published
2012-10-01
Volume
26
Issue
10
Pages
1694-1706
ISSN
  • 0888-8809 (ISSN-L)
  • 1944-9917
OpenAlex
W2154329747
Cited by
47
References
70
Citations by year
2026: 1 · 2025: 3 · 2024: 4 · 2023: 2 · 2022: 1 · 2021: 2 · 2020: 2 · 2019: 4 · 2018: 4 · 2017: 3 · 2016: 5 · 2015: 4 · 2014: 5 · 2013: 7
FWCI
4.12
Type
journal article
Language
en
Open access
Locations
  • Molecular Endocrinology (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Open Access at Essex (University of Essex) (acceptedVersion)
  • UCL Discovery (University College London) (submittedVersion)
Funders
  • Cancer Research UK
  • Imperial College London
  • Université de Genève
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
  • Health Sciences › Medicine › Reproductive Medicine › Sperm and Testicular Function
Keywords
p23, androgen receptor, HSP90, co-chaperones, prostate cancer, castration-resistant prostate cancer, therapeutic target
MeSH terms
Prostaglandin-E Synthases, Animals, Cell Line, Cell Nucleus, Chlorocebus aethiops, Enhancer Elements, Genetic, Humans, Male, Prostatic Neoplasms, Protein Binding, Receptors, Androgen, Receptors, Glucocorticoid, Transcriptional Activation, Gene Expression, Prostate-Specific Antigen, HSP90 Heat-Shock Proteins, Intramolecular Oxidoreductases, Two-Hybrid System Techniques, Tissue Array Analysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.